The relatively frequent presence of partner clones suggests that evaluation of clonal heterogeneity and clonal evolution in CLL would benefit from inclusion of molecular analysis for IGHV-IGHD-IGHJ signatures to distinguish between intra-clonal and inter-clonal diversity. Here, IGHD is linked to B-cell chronic lymphocytic leukemia.